Lithuania vs Sao Tome and Principe: Mortality rate attributed to cardiovascular disease, cancer, diabetes
Lithuania
19.8
in 2021
Sao Tome and Principe
19.5
in 2021
Lithuania rank
94th
Sao Tome and Principe rank
97th
Mortality rate attributed to cardiovascular disease, cancer, diabetes over time
- Lithuania
- Sao Tome and Principe
How they compare
Lithuania currently reports 19.8 against 19.5 in Sao Tome and Principe, a difference of 0.3.
The two have swapped places 2 times across 7 shared years of data; in 2000 it was Lithuania ahead.
Lithuania ranks 94th and Sao Tome and Principe ranks 97th of 197 countries.
Lithuania has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lithuania | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 25 | 20.9 | 4.1 | Lithuania |
| 2010s | 21.9 | 20.1 | 1.8 | Lithuania |
| 2020s | 20.25 | 19.95 | 0.3 | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher mortality rate attributed to cardiovascular disease, cancer, diabetes, Lithuania or Sao Tome and Principe?
- Lithuania, at 19.8 against 19.5 in Sao Tome and Principe as of 2021.
- What is the difference in mortality rate attributed to cardiovascular disease, cancer, diabetes between Lithuania and Sao Tome and Principe?
- 0.3, with Lithuania ahead.
- How many years of comparable data are there for Lithuania and Sao Tome and Principe?
- 7 years are reported by both, from 2000 to 2021.
- How do Lithuania and Sao Tome and Principe rank globally for mortality rate attributed to cardiovascular disease, cancer, diabetes?
- Lithuania ranks 94th and Sao Tome and Principe ranks 97th of 197 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease (probability). Statizoid refreshes it automatically from the source and publishes the full history for both places.